BUDDATE REGES INTENSIVE TREATMENT

Manufacturer
BUDDATE Co Ltd
Effective date
2025-11-30
Label type
HUMAN OTC DRUG LABEL
Version
5
Source
full-release
Hydrated at
2026-06-01 01:18:37

Label at a glance#

ProductBUDDATE REGES INTENSIVE TREATMENT
Active ingredientPALMITOYL TETRAPEPTIDE-7, SHEA BUTTER, PALMITOYL TRIPEPTIDE-1, BUTYLENE GLYCOL, HYDROGENATED COCONUT OIL
Label structure8 sections

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

Butylene Glycol: 5.57 %vv

Hydrogenated Coconut Oil: 4.00 %vv

Butyrospermum Parkii (Shea) Butter: 3.00%vv

Palmitoyl Tripeptide-1: 0.000006 %vv

Palmitoyl Tetrapeptide-7: 0.000006 %vv

INACTIVE INGREDIENT SECTION

Water, Squalane, Triethylhexanoin, 1,2-hexanediol, Cyclomethicone, Stearyl Alcohol, Cetearyl olivate, Simmondsia Chinensis (JoJoba) Seed Oil, BeesWax, Sorbitan olivate, Polyglyceryl-3 Methylglucose Distearate, Phytosterols, Panthenol, Acrylates/C10-30 Alkyl Acrylate Crosspolymer, Arginine, Lecithin, Lavandula Intermedia Oil, Citrus Paradisi (Grapefruit) Peel Oil, Ethylhexylglycerin, Disodium EDTA, Cetyl Hydroxyethylcellulose, Rutin, Phaseolus Lunatus (Green Bean) Seed Extract, Caprylyl Glycol

OTC - PURPOSE SECTION

Humectant & Skin Conditionnig (Protectant)

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

keep out of reach of the children

INDICATIONS & USAGE SECTION

Apply a generous amount of the cream three times a day to your body needing to be nourishd, and then softly massage your skin.

WARNINGS SECTION

1. For external use only.

1) Do not use over the wound and irritated skin with eczema or infections

2) Discontinue using the product if signs of irritations and/or rashes occur and seek professional medical help

2. Keep the cover closed tight after use

3. Do not put the left over contents back into the container to avoid deterioration

1) Avoid contact with eyes

2) Keep out of reach of children

3) Store in a cool and dry place, away from direct sun light

DOSAGE & ADMINISTRATION SECTION

for external use only


PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

11

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
71173-3000-12025-11-30C16284748780-12cef2736-5ba9-d83d-e063-dadaa90ab31fDrug Facts
71173-3000-12025-01-30C16284748780-12cef2736-5ba9-d83d-e063-dadaa90ab31fDrug Facts

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
71173-3000-1BUDDATE REGES INTENSIVE TREATMENT70 mL in 1 TUBECREAM705

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 8 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
71173-300071173-3000-1

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 6 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
BUDDATE REGES INTENSIVE TREATMENTBUTYLENE GLYCOL, HYDROGENATED COCONUT OIL, BUTYROSPERMUM PARKII (SHEA) BUTTER, PALMITOYL TRIPEPTIDE-1, PALMITOYL TETRAPEPTIDE-7BUDDATE Co Ltd46495321-fb14-3479-e054-00144ff88e882025-11-30WarningsExact identifier
ndc (package): 71173-3000-1
ndc (product): 71173-3000
ndc11 (package): 71173300001
spl id: 44ced40a-d974-eb5b-e063-6394a90a4ce6
spl set id: 46495321-fb14-3479-e054-00144ff88e88

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.